Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.90 | €8.27 | 19.896% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.22 | - | - |
| Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €28.60 | - | - |
| Insulet Corp. | 14 | 0 | 1 | 0 | €163.80 | €215.54 | 31.586% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €128.20 | €147.62 | 15.145% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €10.40 | €28.17 | 170.974% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €17.60 | €24.04 | 36.603% |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €23.00 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.13 | - | - |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.32 | €8.36 | 151.966% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 14 | 5 | 3 | 0 | €30.20 | €41.51 | 37.459% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 3 | 0 | €31.00 | €38.99 | 25.770% |
| Radnet Inc. | 7 | 3 | 0 | 0 | €48.40 | €50.90 | 5.159% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 6 | 0 | €66.00 | €79.43 | 20.348% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €0.29 | €7.35 | 2400.544% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.74 | €4.63 | 526.852% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €40.00 | €84.74 | 111.860% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.39 | €3.60 | 159.114% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.84 | - | - |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.42 | €34.41 | 678.566% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.00 | - | - |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €17.15 | - | - |